Figure 3From: Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125 Cytoxic effects of Disorazol-Z and its LHRH conjugate AEZS-125 in (a) HCC1806 and (b) MDA-MB-231; Doxorubicin and and its cytotoxic conjugate in MDA-MB-231 cells (c) as evaluated by CTB assay. Back to article page